1h Free Analyst Time
The protein therapeutics market is forecast to grow by $153.56 bn during 2022-2027, accelerating at a CAGR of 9.14% during the forecast period. The report on the protein therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increased demand for mAbs, the development of novel therapies using innovative technologies, and the availability of favorable reimbursement policies.
The protein therapeutics market is segmented as below:
By Product
- mAbs
- Human insulin
- Erythropoeitin
- Clotting factors
- Others
By Application
- Metabolic disorders
- Immunologic disorders
- Hematological disorders
- Cancer
- Genetic disorders
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the protein therapeutics market covers the following areas:
- Protein therapeutics market sizing
- Protein therapeutics market forecast
- Protein therapeutics market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
Exhibit 06: Executive Summary - Chart on Market Segmentation by Application
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ billion)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ billion)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
4 Historic Market Size
4.1 Global protein therapeutics market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on Global protein therapeutics market 2017 - 2021 ($ billion)
4.2 Product Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - Product Segment 2017 - 2021 ($ billion)
4.3 Application Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - Application Segment 2017 - 2021 ($ billion)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ billion)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ billion)
5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
6 Market Segmentation by Product
6.1 Market segments
Exhibit 30: Chart on Product - Market share 2022-2027 (%)
Exhibit 31: Data Table on Product - Market share 2022-2027 (%)
6.2 Comparison by Product
Exhibit 32: Chart on Comparison by Product
Exhibit 33: Data Table on Comparison by Product
6.3 mAbs - Market size and forecast 2022-2027
Exhibit 34: Chart on mAbs - Market size and forecast 2022-2027 ($ billion)
Exhibit 35: Data Table on mAbs - Market size and forecast 2022-2027 ($ billion)
Exhibit 36: Chart on mAbs - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on mAbs - Year-over-year growth 2022-2027 (%)
6.4 Human insulin - Market size and forecast 2022-2027
Exhibit 38: Chart on Human insulin - Market size and forecast 2022-2027 ($ billion)
Exhibit 39: Data Table on Human insulin - Market size and forecast 2022-2027 ($ billion)
Exhibit 40: Chart on Human insulin - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Human insulin - Year-over-year growth 2022-2027 (%)
6.5 Erythropoeitin - Market size and forecast 2022-2027
Exhibit 42: Chart on Erythropoeitin - Market size and forecast 2022-2027 ($ billion)
Exhibit 43: Data Table on Erythropoeitin - Market size and forecast 2022-2027 ($ billion)
Exhibit 44: Chart on Erythropoeitin - Year-over-year growth 2022-2027 (%)
Exhibit 45: Data Table on Erythropoeitin - Year-over-year growth 2022-2027 (%)
6.6 Clotting factors - Market size and forecast 2022-2027
Exhibit 46: Chart on Clotting factors - Market size and forecast 2022-2027 ($ billion)
Exhibit 47: Data Table on Clotting factors - Market size and forecast 2022-2027 ($ billion)
Exhibit 48: Chart on Clotting factors - Year-over-year growth 2022-2027 (%)
Exhibit 49: Data Table on Clotting factors - Year-over-year growth 2022-2027 (%)
6.7 Others - Market size and forecast 2022-2027
Exhibit 50: Chart on Others - Market size and forecast 2022-2027 ($ billion)
Exhibit 51: Data Table on Others - Market size and forecast 2022-2027 ($ billion)
Exhibit 52: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibit 53: Data Table on Others - Year-over-year growth 2022-2027 (%)
6.8 Market opportunity by Product
Exhibit 54: Market opportunity by Product ($ billion)
Exhibit 55: Data Table on Market opportunity by Product ($ billion)
7 Market Segmentation by Application
7.1 Market segments
Exhibit 56: Chart on Application - Market share 2022-2027 (%)
Exhibit 57: Data Table on Application - Market share 2022-2027 (%)
7.2 Comparison by Application
Exhibit 58: Chart on Comparison by Application
Exhibit 59: Data Table on Comparison by Application
7.3 Metabolic disorders - Market size and forecast 2022-2027
Exhibit 60: Chart on Metabolic disorders - Market size and forecast 2022-2027 ($ billion)
Exhibit 61: Data Table on Metabolic disorders - Market size and forecast 2022-2027 ($ billion)
Exhibit 62: Chart on Metabolic disorders - Year-over-year growth 2022-2027 (%)
Exhibit 63: Data Table on Metabolic disorders - Year-over-year growth 2022-2027 (%)
7.4 Immunologic disorders - Market size and forecast 2022-2027
Exhibit 64: Chart on Immunologic disorders - Market size and forecast 2022-2027 ($ billion)
Exhibit 65: Data Table on Immunologic disorders - Market size and forecast 2022-2027 ($ billion)
Exhibit 66: Chart on Immunologic disorders - Year-over-year growth 2022-2027 (%)
Exhibit 67: Data Table on Immunologic disorders - Year-over-year growth 2022-2027 (%)
7.5 Hematological disorders - Market size and forecast 2022-2027
Exhibit 68: Chart on Hematological disorders - Market size and forecast 2022-2027 ($ billion)
Exhibit 69: Data Table on Hematological disorders - Market size and forecast 2022-2027 ($ billion)
Exhibit 70: Chart on Hematological disorders - Year-over-year growth 2022-2027 (%)
Exhibit 71: Data Table on Hematological disorders - Year-over-year growth 2022-2027 (%)
7.6 Cancer - Market size and forecast 2022-2027
Exhibit 72: Chart on Cancer - Market size and forecast 2022-2027 ($ billion)
Exhibit 73: Data Table on Cancer - Market size and forecast 2022-2027 ($ billion)
Exhibit 74: Chart on Cancer - Year-over-year growth 2022-2027 (%)
Exhibit 75: Data Table on Cancer - Year-over-year growth 2022-2027 (%)
7.7 Genetic disorders - Market size and forecast 2022-2027
Exhibit 76: Chart on Genetic disorders - Market size and forecast 2022-2027 ($ billion)
Exhibit 77: Data Table on Genetic disorders - Market size and forecast 2022-2027 ($ billion)
Exhibit 78: Chart on Genetic disorders - Year-over-year growth 2022-2027 (%)
Exhibit 79: Data Table on Genetic disorders - Year-over-year growth 2022-2027 (%)
7.8 Market opportunity by Application
Exhibit 80: Market opportunity by Application ($ billion)
Exhibit 81: Data Table on Market opportunity by Application ($ billion)
8 Customer Landscape
8.1 Customer landscape overview
Exhibit 82: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 83: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 84: Data Table on Market share By Geographical Landscape 2022-2027 (%)
9.2 Geographic comparison
Exhibit 85: Chart on Geographic comparison
Exhibit 86: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 87: Chart on North America - Market size and forecast 2022-2027 ($ billion)
Exhibit 88: Data Table on North America - Market size and forecast 2022-2027 ($ billion)
Exhibit 89: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 90: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Europe - Market size and forecast 2022-2027
Exhibit 91: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibit 92: Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibit 93: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 94: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.5 Asia - Market size and forecast 2022-2027
Exhibit 95: Chart on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibit 96: Data Table on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibit 97: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 98: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 99: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibit 100: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibit 101: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 102: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 103: Chart on US - Market size and forecast 2022-2027 ($ billion)
Exhibit 104: Data Table on US - Market size and forecast 2022-2027 ($ billion)
Exhibit 105: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 106: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 Canada - Market size and forecast 2022-2027
Exhibit 107: Chart on Canada - Market size and forecast 2022-2027 ($ billion)
Exhibit 108: Data Table on Canada - Market size and forecast 2022-2027 ($ billion)
Exhibit 109: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibit 110: Data Table on Canada - Year-over-year growth 2022-2027 (%)
9.9 Germany - Market size and forecast 2022-2027
Exhibit 111: Chart on Germany - Market size and forecast 2022-2027 ($ billion)
Exhibit 112: Data Table on Germany - Market size and forecast 2022-2027 ($ billion)
Exhibit 113: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 114: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.10 UK - Market size and forecast 2022-2027
Exhibit 115: Chart on UK - Market size and forecast 2022-2027 ($ billion)
Exhibit 116: Data Table on UK - Market size and forecast 2022-2027 ($ billion)
Exhibit 117: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibit 118: Data Table on UK - Year-over-year growth 2022-2027 (%)
9.11 China - Market size and forecast 2022-2027
Exhibit 119: Chart on China - Market size and forecast 2022-2027 ($ billion)
Exhibit 120: Data Table on China - Market size and forecast 2022-2027 ($ billion)
Exhibit 121: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 122: Data Table on China - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 123: Market opportunity By Geographical Landscape ($ billion)
Exhibit 124: Data Tables on Market opportunity By Geographical Landscape ($ billion)
10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 125: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends
11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 126: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 127: Overview on factors of disruption
11.4 Industry risks
Exhibit 128: Impact of key risks on business
12 Vendor Analysis
12.1 Vendors covered
Exhibit 129: Vendors covered
12.2 Market positioning of vendors
Exhibit 130: Matrix on vendor position and classification
12.3 AbbVie Inc.
Exhibit 131: AbbVie Inc. - Overview
Exhibit 132: AbbVie Inc. - Product / Service
Exhibit 133: AbbVie Inc. - Key news
Exhibit 134: AbbVie Inc. - Key offerings
12.4 Amgen Inc.
Exhibit 135: Amgen Inc. - Overview
Exhibit 136: Amgen Inc. - Product / Service
Exhibit 137: Amgen Inc. - Key offerings
12.5 AstraZeneca Plc
Exhibit 138: AstraZeneca Plc - Overview
Exhibit 139: AstraZeneca Plc - Product / Service
Exhibit 140: AstraZeneca Plc - Key news
Exhibit 141: AstraZeneca Plc - Key offerings
12.6 Biogen Inc.
Exhibit 142: Biogen Inc. - Overview
Exhibit 143: Biogen Inc. - Product / Service
Exhibit 144: Biogen Inc. - Key offerings
12.7 Bristol Myers Squibb Co.
Exhibit 145: Bristol Myers Squibb Co. - Overview
Exhibit 146: Bristol Myers Squibb Co. - Product / Service
Exhibit 147: Bristol Myers Squibb Co. - Key news
Exhibit 148: Bristol Myers Squibb Co. - Key offerings
12.8 Creative Biolabs
Exhibit 149: Creative Biolabs - Overview
Exhibit 150: Creative Biolabs - Product / Service
Exhibit 151: Creative Biolabs - Key offerings
12.9 Eli Lilly and Co.
Exhibit 152: Eli Lilly and Co. - Overview
Exhibit 153: Eli Lilly and Co. - Product / Service
Exhibit 154: Eli Lilly and Co. - Key offerings
12.10 F. Hoffmann La Roche Ltd.
Exhibit 155: F. Hoffmann La Roche Ltd. - Overview
Exhibit 156: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 157: F. Hoffmann La Roche Ltd. - Key news
Exhibit 158: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 159: F. Hoffmann La Roche Ltd. - Segment focus
12.11 Ipsen Pharma
Exhibit 160: Ipsen Pharma - Overview
Exhibit 161: Ipsen Pharma - Business segments
Exhibit 162: Ipsen Pharma - Key offerings
Exhibit 163: Ipsen Pharma - Segment focus
12.12 Johnson and Johnson Services Inc.
Exhibit 164: Johnson and Johnson Services Inc. - Overview
Exhibit 165: Johnson and Johnson Services Inc. - Business segments
Exhibit 166: Johnson and Johnson Services Inc. - Key news
Exhibit 167: Johnson and Johnson Services Inc. - Key offerings
Exhibit 168: Johnson and Johnson Services Inc. - Segment focus
12.13 LGM Pharma LLC
Exhibit 169: LGM Pharma LLC - Overview
Exhibit 170: LGM Pharma LLC - Product / Service
Exhibit 171: LGM Pharma LLC - Key offerings
12.14 Novartis AG
Exhibit 172: Novartis AG - Overview
Exhibit 173: Novartis AG - Business segments
Exhibit 174: Novartis AG - Key offerings
Exhibit 175: Novartis AG - Segment focus
12.15 Novo Nordisk AS
Exhibit 176: Novo Nordisk AS - Overview
Exhibit 177: Novo Nordisk AS - Business segments
Exhibit 178: Novo Nordisk AS - Key offerings
Exhibit 179: Novo Nordisk AS - Segment focus
12.16 Pfizer Inc.
Exhibit 180: Pfizer Inc. - Overview
Exhibit 181: Pfizer Inc. - Product / Service
Exhibit 182: Pfizer Inc. - Key news
Exhibit 183: Pfizer Inc. - Key offerings
12.17 Sanofi SA
Exhibit 184: Sanofi SA - Overview
Exhibit 185: Sanofi SA - Business segments
Exhibit 186: Sanofi SA - Key news
Exhibit 187: Sanofi SA - Key offerings
Exhibit 188: Sanofi SA - Segment focus
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 189: Inclusions checklist
Exhibit 190: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 191: Currency conversion rates for US$
13.4 Research methodology
Exhibit 192: Research methodology
Exhibit 193: Validation techniques employed for market sizing
Exhibit 194: Information sources
13.5 List of abbreviations
Exhibit 195: List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Product
Exhibits 6: Executive Summary - Chart on Market Segmentation by Application
Exhibits 7: Executive Summary - Chart on Incremental Growth
Exhibits 8: Executive Summary - Data Table on Incremental Growth
Exhibits 9: Executive Summary - Chart on Vendor Market Positioning
Exhibits 10: Parent market
Exhibits 11: Market Characteristics
Exhibits 12: Offerings of vendors included in the market definition
Exhibits 13: Market segments
Exhibits 14: Chart on Global - Market size and forecast 2022-2027 ($ billion)
Exhibits 15: Data Table on Global - Market size and forecast 2022-2027 ($ billion)
Exhibits 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits 18: Historic Market Size - Data Table on Global protein therapeutics market 2017 - 2021 ($ billion)
Exhibits 19: Historic Market Size - Product Segment 2017 - 2021 ($ billion)
Exhibits 20: Historic Market Size - Application Segment 2017 - 2021 ($ billion)
Exhibits 21: Historic Market Size - Geography Segment 2017 - 2021 ($ billion)
Exhibits 22: Historic Market Size - Country Segment 2017 - 2021 ($ billion)
Exhibits 23: Five forces analysis - Comparison between 2022 and 2027
Exhibits 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits 26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits 27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits 28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits 29: Chart on Market condition - Five forces 2022 and 2027
Exhibits 30: Chart on Product - Market share 2022-2027 (%)
Exhibits 31: Data Table on Product - Market share 2022-2027 (%)
Exhibits 32: Chart on Comparison by Product
Exhibits 33: Data Table on Comparison by Product
Exhibits 34: Chart on mAbs - Market size and forecast 2022-2027 ($ billion)
Exhibits 35: Data Table on mAbs - Market size and forecast 2022-2027 ($ billion)
Exhibits 36: Chart on mAbs - Year-over-year growth 2022-2027 (%)
Exhibits 37: Data Table on mAbs - Year-over-year growth 2022-2027 (%)
Exhibits 38: Chart on Human insulin - Market size and forecast 2022-2027 ($ billion)
Exhibits 39: Data Table on Human insulin - Market size and forecast 2022-2027 ($ billion)
Exhibits 40: Chart on Human insulin - Year-over-year growth 2022-2027 (%)
Exhibits 41: Data Table on Human insulin - Year-over-year growth 2022-2027 (%)
Exhibits 42: Chart on Erythropoeitin - Market size and forecast 2022-2027 ($ billion)
Exhibits 43: Data Table on Erythropoeitin - Market size and forecast 2022-2027 ($ billion)
Exhibits 44: Chart on Erythropoeitin - Year-over-year growth 2022-2027 (%)
Exhibits 45: Data Table on Erythropoeitin - Year-over-year growth 2022-2027 (%)
Exhibits 46: Chart on Clotting factors - Market size and forecast 2022-2027 ($ billion)
Exhibits 47: Data Table on Clotting factors - Market size and forecast 2022-2027 ($ billion)
Exhibits 48: Chart on Clotting factors - Year-over-year growth 2022-2027 (%)
Exhibits 49: Data Table on Clotting factors - Year-over-year growth 2022-2027 (%)
Exhibits 50: Chart on Others - Market size and forecast 2022-2027 ($ billion)
Exhibits 51: Data Table on Others - Market size and forecast 2022-2027 ($ billion)
Exhibits 52: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibits 53: Data Table on Others - Year-over-year growth 2022-2027 (%)
Exhibits 54: Market opportunity by Product ($ billion)
Exhibits 55: Data Table on Market opportunity by Product ($ billion)
Exhibits 56: Chart on Application - Market share 2022-2027 (%)
Exhibits 57: Data Table on Application - Market share 2022-2027 (%)
Exhibits 58: Chart on Comparison by Application
Exhibits 59: Data Table on Comparison by Application
Exhibits 60: Chart on Metabolic disorders - Market size and forecast 2022-2027 ($ billion)
Exhibits 61: Data Table on Metabolic disorders - Market size and forecast 2022-2027 ($ billion)
Exhibits 62: Chart on Metabolic disorders - Year-over-year growth 2022-2027 (%)
Exhibits 63: Data Table on Metabolic disorders - Year-over-year growth 2022-2027 (%)
Exhibits 64: Chart on Immunologic disorders - Market size and forecast 2022-2027 ($ billion)
Exhibits 65: Data Table on Immunologic disorders - Market size and forecast 2022-2027 ($ billion)
Exhibits 66: Chart on Immunologic disorders - Year-over-year growth 2022-2027 (%)
Exhibits 67: Data Table on Immunologic disorders - Year-over-year growth 2022-2027 (%)
Exhibits 68: Chart on Hematological disorders - Market size and forecast 2022-2027 ($ billion)
Exhibits 69: Data Table on Hematological disorders - Market size and forecast 2022-2027 ($ billion)
Exhibits 70: Chart on Hematological disorders - Year-over-year growth 2022-2027 (%)
Exhibits 71: Data Table on Hematological disorders - Year-over-year growth 2022-2027 (%)
Exhibits 72: Chart on Cancer - Market size and forecast 2022-2027 ($ billion)
Exhibits 73: Data Table on Cancer - Market size and forecast 2022-2027 ($ billion)
Exhibits 74: Chart on Cancer - Year-over-year growth 2022-2027 (%)
Exhibits 75: Data Table on Cancer - Year-over-year growth 2022-2027 (%)
Exhibits 76: Chart on Genetic disorders - Market size and forecast 2022-2027 ($ billion)
Exhibits 77: Data Table on Genetic disorders - Market size and forecast 2022-2027 ($ billion)
Exhibits 78: Chart on Genetic disorders - Year-over-year growth 2022-2027 (%)
Exhibits 79: Data Table on Genetic disorders - Year-over-year growth 2022-2027 (%)
Exhibits 80: Market opportunity by Application ($ billion)
Exhibits 81: Data Table on Market opportunity by Application ($ billion)
Exhibits 82: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 83: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits 84: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits 85: Chart on Geographic comparison
Exhibits 86: Data Table on Geographic comparison
Exhibits 87: Chart on North America - Market size and forecast 2022-2027 ($ billion)
Exhibits 88: Data Table on North America - Market size and forecast 2022-2027 ($ billion)
Exhibits 89: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits 90: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits 91: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibits 92: Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibits 93: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits 94: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits 95: Chart on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibits 96: Data Table on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibits 97: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits 98: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits 99: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibits 100: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibits 101: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits 102: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits 103: Chart on US - Market size and forecast 2022-2027 ($ billion)
Exhibits 104: Data Table on US - Market size and forecast 2022-2027 ($ billion)
Exhibits 105: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits 106: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits 107: Chart on Canada - Market size and forecast 2022-2027 ($ billion)
Exhibits 108: Data Table on Canada - Market size and forecast 2022-2027 ($ billion)
Exhibits 109: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibits 110: Data Table on Canada - Year-over-year growth 2022-2027 (%)
Exhibits 111: Chart on Germany - Market size and forecast 2022-2027 ($ billion)
Exhibits 112: Data Table on Germany - Market size and forecast 2022-2027 ($ billion)
Exhibits 113: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits 114: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits 115: Chart on UK - Market size and forecast 2022-2027 ($ billion)
Exhibits 116: Data Table on UK - Market size and forecast 2022-2027 ($ billion)
Exhibits 117: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits 118: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits 119: Chart on China - Market size and forecast 2022-2027 ($ billion)
Exhibits 120: Data Table on China - Market size and forecast 2022-2027 ($ billion)
Exhibits 121: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits 122: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits 123: Market opportunity By Geographical Landscape ($ billion)
Exhibits 124: Data Tables on Market opportunity By Geographical Landscape ($ billion)
Exhibits 125: Impact of drivers and challenges in 2022 and 2027
Exhibits 126: Overview on Criticality of inputs and Factors of differentiation
Exhibits 127: Overview on factors of disruption
Exhibits 128: Impact of key risks on business
Exhibits 129: Vendors covered
Exhibits 130: Matrix on vendor position and classification
Exhibits 131: AbbVie Inc. - Overview
Exhibits 132: AbbVie Inc. - Product / Service
Exhibits 133: AbbVie Inc. - Key news
Exhibits 134: AbbVie Inc. - Key offerings
Exhibits 135: Amgen Inc. - Overview
Exhibits 136: Amgen Inc. - Product / Service
Exhibits 137: Amgen Inc. - Key offerings
Exhibits 138: AstraZeneca Plc - Overview
Exhibits 139: AstraZeneca Plc - Product / Service
Exhibits 140: AstraZeneca Plc - Key news
Exhibits 141: AstraZeneca Plc - Key offerings
Exhibits 142: Biogen Inc. - Overview
Exhibits 143: Biogen Inc. - Product / Service
Exhibits 144: Biogen Inc. - Key offerings
Exhibits 145: Bristol Myers Squibb Co. - Overview
Exhibits 146: Bristol Myers Squibb Co. - Product / Service
Exhibits 147: Bristol Myers Squibb Co. - Key news
Exhibits 148: Bristol Myers Squibb Co. - Key offerings
Exhibits 149: Creative Biolabs - Overview
Exhibits 150: Creative Biolabs - Product / Service
Exhibits 151: Creative Biolabs - Key offerings
Exhibits 152: Eli Lilly and Co. - Overview
Exhibits 153: Eli Lilly and Co. - Product / Service
Exhibits 154: Eli Lilly and Co. - Key offerings
Exhibits 155: F. Hoffmann La Roche Ltd. - Overview
Exhibits 156: F. Hoffmann La Roche Ltd. - Business segments
Exhibits 157: F. Hoffmann La Roche Ltd. - Key news
Exhibits 158: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits 159: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits 160: Ipsen Pharma - Overview
Exhibits 161: Ipsen Pharma - Business segments
Exhibits 162: Ipsen Pharma - Key offerings
Exhibits 163: Ipsen Pharma - Segment focus
Exhibits 164: Johnson and Johnson Services Inc. - Overview
Exhibits 165: Johnson and Johnson Services Inc. - Business segments
Exhibits 166: Johnson and Johnson Services Inc. - Key news
Exhibits 167: Johnson and Johnson Services Inc. - Key offerings
Exhibits 168: Johnson and Johnson Services Inc. - Segment focus
Exhibits 169: LGM Pharma LLC - Overview
Exhibits 170: LGM Pharma LLC - Product / Service
Exhibits 171: LGM Pharma LLC - Key offerings
Exhibits 172: Novartis AG - Overview
Exhibits 173: Novartis AG - Business segments
Exhibits 174: Novartis AG - Key offerings
Exhibits 175: Novartis AG - Segment focus
Exhibits 176: Novo Nordisk AS - Overview
Exhibits 177: Novo Nordisk AS - Business segments
Exhibits 178: Novo Nordisk AS - Key offerings
Exhibits 179: Novo Nordisk AS - Segment focus
Exhibits 180: Pfizer Inc. - Overview
Exhibits 181: Pfizer Inc. - Product / Service
Exhibits 182: Pfizer Inc. - Key news
Exhibits 183: Pfizer Inc. - Key offerings
Exhibits 184: Sanofi SA - Overview
Exhibits 185: Sanofi SA - Business segments
Exhibits 186: Sanofi SA - Key news
Exhibits 187: Sanofi SA - Key offerings
Exhibits 188: Sanofi SA - Segment focus
Exhibits 189: Inclusions checklist
Exhibits 190: Exclusions checklist
Exhibits 191: Currency conversion rates for US$
Exhibits 192: Research methodology
Exhibits 193: Validation techniques employed for market sizing
Exhibits 194: Information sources
Exhibits 195: List of abbreviations
Executive Summary
The publisher recognizes the following companies as the key players in the global protein therapeutics market: AbbVie Inc., Amgen Inc., AstraZeneca Plc, Biocon Ltd., Biogen Inc., Bristol Myers Squibb Co., Celltrion Healthcare Co. Ltd., Creative Biolabs, Eli Lilly and Co., F. Hoffmann La Roche Ltd., Intas Pharmaceuticals Ltd., Ipsen Pharma, Johnson and Johnson Services Inc., LGM Pharma LLC, Midas Pharma GmbH, Novartis AG, Novo Nordisk AS, Pfizer Inc., PV Pharma Healthcare Pvt. Ltd., and Sanofi SA.Commenting on the report, an analyst from the research team said: `The latest trend gaining momentum in the market is focus on product improvement.`
According to the report, one of the major drivers for this market is the increased demand for mAbs.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AbbVie Inc.
- Amgen Inc.
- AstraZeneca Plc
- Biocon Ltd.
- Biogen Inc.
- Bristol Myers Squibb Co.
- Celltrion Healthcare Co. Ltd.
- Creative Biolabs
- Eli Lilly and Co.
- F. Hoffmann La Roche Ltd.
- Intas Pharmaceuticals Ltd.
- Ipsen Pharma
- Johnson and Johnson Services Inc.
- LGM Pharma LLC
- Midas Pharma GmbH
- Novartis AG
- Novo Nordisk AS
- Pfizer Inc.
- PV Pharma Healthcare Pvt. Ltd.
- Sanofi SA
